English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17778/20119 (88%)
Visitors : 12264037      Online Users : 204
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32690

    標題: Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively
    作者: Kuo, Chun-Heng
    Jung-Nan Wei(魏榮男)
    Yang, Chung-Yi
    Ou, Horng-Yih
    Wu, Hung-Tsung
    Fan, Kang-Chih
    Wang, Shu-Huei
    Hua, Cyue-Huei
    Ching-Hsiang Hsiao(蕭景祥)
    Mei-Kuei Lee(李美貴)
    Li, Hung-Yuan
    貢獻者: Fu Jen Catholic Univ Hosp, Dept Internal Med
    Chia Nan Univ Pharm & Sci
    I Shou Univ, E Da Hosp, Dept Med Imaging
    Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med
    Taipei Med Univ, Grad Inst Metab & Obes Sci
    Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch
    Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med
    Natl Taiwan Univ Hosp, Div Clin Pathol, Yun Lin Branch
    Natl Taiwan Univ Hosp, Dept Internal Med
    日期: 2019-03
    上傳時間: 2020-07-29 13:55:26 (UTC+8)
    摘要: Background/objectives Vascular adhesion protein-1 (VAP-1) can enhance tissue glucose uptake in cell studies and normalize hyperglycemia in animal studies. However, serum VAP-1 concentration (sVAP-1) is higher in subjects with diabetes in cross-sectional studies. In this cohort study, we test our hypothesis that sVAP-1 is increased in prediabetes to counteract hyperglycemia and is associated with incident diabetes negatively. Subjects/methods From 2006 to 2012, 600 subjects without diabetes from Taiwan Lifestyle Study were included and followed regularly. Diabetes was diagnosed if FPG >= 126 mg/dL (7 mmol/L), 2-h plasma glucose (2hPG) during an oral glucose tolerance test (OGTT) >= 200 mg/dL (11.1 mmol/L), or hemoglobin A1c (HbA1c) >= 6.5%, or if the subject received anti-diabetic medications. Abdominal fat areas were measured by abdominal computed tomography and sVAP-1 was analyzed by ELISA. Results sVAP-1 was higher in subjects with prediabetes (p < 0.05) and increased during an OGTT (p <0 .001). Fasting sVAP-1 was associated with the response of sVAP-1 during an OGTT (p < 0.001). Besides, sVAP-1 was associated negatively with body mass index (BMI, r = -0.1449, p = 0.003), waist circumference (r = -0.1425, p = 0.004), abdominal visceral (r = -0.1457, p = 0.003), and subcutaneous (r = -0.1025, p = 0.035) fat areas, and serum high-sensitivity C-reactive protein (hsCRP) concentration (r = -0.2035, p < 0.0001), and positively with plasma adiponectin concentration (r = 0.2086, p < 0.0001), adjusted for age and gender. After 4.7 +/- 2.6 years, 73 subjects (12.2%) developed incident diabetes. High sVAP-1 predicted a lower incidence of diabetes, adjusted for age, gender, BMI, family history of diabetes, HbA1c, HOMA2-%B and HOMA2-IR (HR = 0.66, 95% CI = 0.50-0.88, p < 0.01). Conclusions sVAP-1 is increased in response to hyperglycemia. It is associated with obesity and serum hsCRP concentration negatively, and plasma adiponectin concentration positively. Besides, a high sVAP-1 is associated with a lower incidence of diabetes in human.
    關聯: International Journal of Obesity, v.43, n.3, pp.512-522
    Appears in Collections:[應用空間資訊系(所)] 期刊論文
    [職業安全衛生系(含防災所)] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback